Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
---|---|---|---|---|---|
Gross Sales | 310.16 | 251.91 | 226.78 | 144.85 | 189.2 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 310.16 | 251.91 | 226.78 | 144.85 | 189.2 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.71 | 1.18 | 1.36 | 0.47 | 0.34 |
Total Income | 311.87 | 253.09 | 228.14 | 145.32 | 189.54 |
Total Expenditure | 236.22 | 196.64 | 174.02 | 113.74 | 150.2 |
PBIDT | 75.65 | 56.44 | 54.11 | 31.58 | 39.34 |
Interest | 19.33 | 14.88 | 15.6 | 14.71 | 13.58 |
PBDT | 56.32 | 41.56 | 38.52 | 16.87 | 25.75 |
Depreciation | 8.13 | 7.2 | 5.98 | 5.32 | 5.27 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 12.02 | 7.04 | 4.19 | 1.73 | 2.65 |
Deferred Tax | 3.97 | 3.16 | 5.45 | 1.61 | 4.02 |
Reported Profit After Tax | 32.2 | 24.16 | 22.89 | 8.21 | 13.81 |
Minority Interest After NP | -0.06 | 0.03 | -0.01 | 0 | -0.01 |
Net Profit after Minority Interest | 32.26 | 24.13 | 22.9 | 8.22 | 13.82 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | -3.22 |
Adjusted Profit After Extra-ordinary item | 32.26 | 24.13 | 22.9 | 8.22 | 17.04 |
EPS (Unit Curr.) | 1.05 | 0.8 | 0.81 | 0.37 | 6.66 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 30.65 | 30.65 | 28.24 | 23.3 | 20.76 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 24.39 | 22.4 | 23.86 | 21.8 | 20.79 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 10.38 | 9.59 | 10.09 | 5.66 | 7.29 |
The board approved the issuing of 2.45 Crore convertible equity warrants on a preferential basis to promoters and non-promoter businesses.
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.